Covid: Australian garlic eliminates coronavirus and influenza with '99.9 percent adequacy," a new review finds.

Introduction:

Garlic has long been celebrated for its antibacterial properties and is a staple in traditional Chinese medicine. A groundbreaking study has emerged, claiming that specific Australian garlic varieties possess the remarkable ability to neutralize coronaviruses, including SARS-CoV-2, and the common flu virus with an astonishing 99.9% effectiveness. The new research, released by the Peter Doherty Institute, has garnered significant attention.

Antiviral Properties of Garlic:

Scientists at the Doherty Institute have dedicated months to investigating the antiviral properties of garlic. 

Their findings indicate that certain Australian-grown garlic varieties exhibit antiviral properties, rendering them up to 99.9% effective against SARS-CoV-2 and influenza type A viruses.

About the Study

This research involved in vitro testing against SARS-CoV-2 and influenza type A viruses, utilizing garlic components extracted from select Australian garlic varieties.

What Researchers Have to Say

Dr. Julie McAuley, Director of the Doherty's high-containment coronavirus research laboratory, expressed her astonishment: "We were curious to see if these strains had the potential to combat coronaviruses. 

I thought it could be a long shot. We blindly tested more than 20 varieties. We found that one of AGP's products could reduce the infectious titer of SARS-CoV-2 and influenza by 3-log-fold (99.9%). We barely detected any remaining virus genome, indicating almost complete virucidal activity."

Dr. McAuley emphasized that the variety was tested across multiple sites to ensure that the results were not influenced by environmental factors such as nutrients, water, or any other variables.

Clinical Trials and Real-World Implications:

While these findings are remarkable, it's important to note that rigorous clinical trials are essential to determine whether the potential demonstrated in the laboratory translates to actual benefits for humans. 

Gideon Meyerowitz-Katz, an epidemiologist at the University of Wollongong, stressed the need for clinical trials in real individuals, stating, "We won't know if this product helps with coronavirus or flu until we conduct clinical trials in real people, as opposed to petri dishes in a lab."

Garlic Pills for Immunity:

Reports suggest that the most promising garlic varieties and their proprietary garlic components are being developed into a soft capsule supplement. These supplements are intended to boost immunity and may become available for consumption. Importantly, they are subject to a recently acquired global patent.

Paul Guerra, CEO of the Victorian Department of Trade and Industry, who unveiled the study, believes that this discovery has the potential to be a game-changer and could be exported globally.